OcuSciences puts diabetes test through clinical trials, adds two jobs

OcuSciences continues to grow its staff as it pushes forward its development of an ocular test for diabetes, hiring two University of Michigan graduates in recent months.

The University of Michigan spin-out is developing an ocular diagnostic technology for metabolomic diseases. In layman's terms, that technology allows doctors to diagnose patients with diseases like diabetes by scanning their eyes. The process has the potential to be more accurate and catch a diabetes diagnosis much earlier than traditional methods.

The three-year-old start-up's eight-person team has been in clinical trials since 2008 and expects to continue testing and developing the third generation of its product next year. That will probably mean a few more hires for the fledgling firm.

"With our product team in place we will do more of our development in Michigan," says Kurt Riegger, COO of OcuSciences.

OcuSciences recently won the Life Sciences Award at the Accelerate Michigan Innovation Competition in Ypsilanti. The company took home a $25,000 check and some credibility with both local and out-of-state investors. "It's a good validation," Riegger says.

Source: Kurt Riegger, COO of OcuSciences
Writer: Jon Zemke

Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.

Related Company